Cannabis is a complex category and new to most ad tech buyers and sellers. It shares the challenges of product categories such as alcohol, tobacco and prescription medicine, but adds on evolving state-by state legislation, unclear advertising guidelines, brand safety and brand suitability concerns, and a general consumer bias, making it a particularly tricky category.
With a projected revenue of $30 billion by 2025 [1] the following considerations are paramount to the success and growth of the U.S. cannabis industry: what the cannabis regulatory landscape entails, how the standard regulatory bodies weigh in, the ongoing challenges this creates for programmatic advertising, and how this should be approached by media professionals within the programmatic ecosystem.
In 2020, the . . .
You must be an IAB Member to continue reading.To receive IAB member benefits, you must be employed by one of our member companies and have a verified business email address associated with your account.
If you have an IAB Portal account, please create a new account on iab.com and we will link to your records. If you're logged in and believe you are seeing this message in error, log out and try with another account or contact us about your company's membership status.Contact [email protected] with press inquiries. |
